(Q37756812)

22 August 2017

1 reference

title

Characteristics of obesity and its related disorders in China (English)

1 reference

People's Republic of China

22 August 2017

0 references

0 references

author name string

Wei-Ping Jia

1

1 reference

22 August 2017

Chen Wang

2

1 reference

22 August 2017

Shan Jiang

3

1 reference

22 August 2017

Jie-Min Pan

4

1 reference

22 August 2017

publication date

1 February 2010

1 reference

22 August 2017

number of pages

8

1 reference

Biomedical and Environmental Sciences

inferred from page(s)

published in

1 reference

22 August 2017

volume

23

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

4-11

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Abdominal obesity and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Overweight and obesity in China

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Prevalence of overweight and obesity in the United States, 1999-2004

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Trends in the distribution of body mass index among Chinese adults, aged 20-45 years (1989-2000).

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Risk factors for overweight and obesity, and changes in body mass index of Chinese adults in Shanghai

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Prevalence of overweight and obesity among 2.6 million rural Chinese adults

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

A comparison of two proposed definitions for metabolic syndrome in the Chinese adult population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Cardiovascular diseases in China

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

CVD risk factors and ethnicity--a homogeneous relationship?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Optimal waist circumference cutoffs for abdominal obesity in Chinese.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Identification of waist circumference cutoffs for abdominal obesity in the Chinese population: a 7.8-year follow-up study in the Shanghai urban area

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Manifestation of cardiovascular risk factors at low levels of body mass index and waist-to-hip ratio in Singaporean Chinese.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Health risks among Japanese men with moderate body mass index

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Body fat by dual photon absorptiometry: Comparisons with traditional methods in Asians, blacks, and whites

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

New criteria for 'obesity disease' in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Adiponectin and metabolic syndrome in middle-aged and elderly Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Adipose tissue: from lipid storage compartment to endocrine organ

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

c-Reactive protein and the metabolic syndrome in older Chinese: Guangzhou Biobank Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Association of C-reactive protein and metabolic syndrome in a rural Chinese population.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Elevated C-reactive protein levels in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Sarcopenic obesity and inflammation in the InCHIANTI study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Metabolic syndrome and incident diabetes: current state of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a chinese population with high postprandial glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-3988%2810%2960025-6

7 January 2021

10.1016/S0895-3988(10)60025-6

Identifiers

DOI

1 reference

22 August 2017

1 reference